Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial.
Saved in:
| Title: | Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. |
|---|---|
| Authors: | Meng, Xiangrui1 (AUTHOR), Yang, Xiuli2 (AUTHOR), Hong, Yonggui3 (AUTHOR), Wang, Wenkang4 (AUTHOR), Zhang, Zhiye5 (AUTHOR), Xia, Jin3 (AUTHOR), Chen, Yunfang6 (AUTHOR), Zhou, Yue7 (AUTHOR), Lu, Taiying1 (AUTHOR), Song, Min1 (AUTHOR), Shan, Zhengzheng1 (AUTHOR), Wu, Tao3 (AUTHOR), Wu, Weilong3 (AUTHOR), Shen, Ling2 (AUTHOR), Guan, Lulu1 (AUTHOR), Ma, Mingying5 (AUTHOR), Wang, Lisen6 (AUTHOR), Luo, Xi1 (AUTHOR), Xin, Dao1 (AUTHOR), Ma, Yihui8 (AUTHOR) |
| Source: | Molecular Cancer. 6/11/2025, Vol. 24 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 185858764 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Meng%2C+Xiangrui%22">Meng, Xiangrui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Xiuli%22">Yang, Xiuli</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hong%2C+Yonggui%22">Hong, Yonggui</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Wenkang%22">Wang, Wenkang</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Zhiye%22">Zhang, Zhiye</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xia%2C+Jin%22">Xia, Jin</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Yunfang%22">Chen, Yunfang</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Yue%22">Zhou, Yue</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Taiying%22">Lu, Taiying</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Min%22">Song, Min</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shan%2C+Zhengzheng%22">Shan, Zhengzheng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Tao%22">Wu, Tao</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Weilong%22">Wu, Weilong</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+Ling%22">Shen, Ling</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guan%2C+Lulu%22">Guan, Lulu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Mingying%22">Ma, Mingying</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Lisen%22">Wang, Lisen</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luo%2C+Xi%22">Luo, Xi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xin%2C+Dao%22">Xin, Dao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Yihui%22">Ma, Yihui</searchLink><relatesTo>8</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Molecular+Cancer%22">Molecular Cancer</searchLink>. 6/11/2025, Vol. 24 Issue 1, p1-13. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=185858764 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12943-025-02376-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 1 Titles: – TitleFull: Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Meng, Xiangrui – PersonEntity: Name: NameFull: Yang, Xiuli – PersonEntity: Name: NameFull: Hong, Yonggui – PersonEntity: Name: NameFull: Wang, Wenkang – PersonEntity: Name: NameFull: Zhang, Zhiye – PersonEntity: Name: NameFull: Xia, Jin – PersonEntity: Name: NameFull: Chen, Yunfang – PersonEntity: Name: NameFull: Zhou, Yue – PersonEntity: Name: NameFull: Lu, Taiying – PersonEntity: Name: NameFull: Song, Min – PersonEntity: Name: NameFull: Shan, Zhengzheng – PersonEntity: Name: NameFull: Wu, Tao – PersonEntity: Name: NameFull: Wu, Weilong – PersonEntity: Name: NameFull: Shen, Ling – PersonEntity: Name: NameFull: Guan, Lulu – PersonEntity: Name: NameFull: Ma, Mingying – PersonEntity: Name: NameFull: Wang, Lisen – PersonEntity: Name: NameFull: Luo, Xi – PersonEntity: Name: NameFull: Xin, Dao – PersonEntity: Name: NameFull: Ma, Yihui IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 06 Text: 6/11/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 14764598 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: Molecular Cancer Type: main |
| ResultId | 1 |